Myomas and reproductive function

Fertility and Sterility

Volumn 86, Issue 5 SUPPL., 2006, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DANAZOL; GESTAGEN; GESTRINONE; GONADORELIN DERIVATIVE; IRON; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT; POLYVINYL ALCOHOL; STEROID HORMONE;

AMENORRHEA; ARTICLE; CANCER INHIBITION; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; FEMALE INFERTILITY; HUMAN; HYSTERECTOMY; HYSTEROSALPINGOGRAPHY; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; MYOMECTOMY; OUTCOME ASSESSMENT; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT OUTCOME; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA;

FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INFERTILITY, FEMALE; LEIOMYOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; REPRODUCTION; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 33750026983     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.08.026     Document Type: Article

References (70)

1. Buttram Jr. V.C., and Reiter R.C. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 36 (1981) 433-435
2. Dicker R.C., Greenspan J.R., Strauss L.T., Cowart M.R., Scally M.J., Peterson H.B., et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States. The Collaborative Review of Sterilization. Am J Obstet Gynecol 144 (1982) 841-848
3. Gambone J.C., Reiter R.C., Lench J.B., and Moore J.G. The impact of a quality assurance process on the frequency and confirmation rates of hysterectomy. Am J Obstet Gynecol 163 (1990) 545-550
4. Townsend D.E., Sparkes R.S., Baluda M.C., and McClelland G. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107 (1970) 1168-1173
5. Rein M.S., Friedman A.J., Barbieri R.L., Pavelka K., Fletcher J.A., and Morton C.C. Cytogenic abnormalities in uterine leiomyomata. Obstet Gynecol 77 (1991) 923-926
6. Pollow K., Sinnecker G., Boquoi E., and Pollow B. In vitro conversion of estradiol-17beta into estrone in normal human myometrium and leiomyoma. J Clin Chem Clin Biochem 16 (1978) 493-502
7. Tommola P., Pekonen F., and Rutanen E.M. Binding of epidermal growth factor and insulin-like growth factor I in human myometrium and leiomyomata. Obstet Gynecol 74 (1989) 658-662
8. Fayed Y.M., Tsibris J.C., Langenberg P.W., and Robertson Jr. A.L. Human uterine leiomyoma cells: binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab Invest 60 (1989) 30-37
9. Lumsden M.A., West C.P., Hawkins R.A., Bramley T.A., Rumgay L., and Baird D.T. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630). J Endocrinol 121 (1989) 389-396
10. Farhi J., Ashkenazi J., Feldberg D., Dicker D., Orvieto R., and Ben Rafael Z. Effect of uterine leiomyomata on the results of in-vitro fertilization treatment. Hum Reprod 10 (1995) 2576-2578
11. Rice J.P., Kay H.H., and Mahony B.S. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol 160 (1989) 1212-1216
12. Burton C.A., Grimes D.A., and March C.M. Surgical management of leiomyomata during pregnancy. Obstet Gynecol 74 (1989) 707-709
13. Lev-Toaff A.S., Coleman B.G., Arger P.H., Mintz M.C., Arenson R.L., and Toaff M.E. Leiomyomas in pregnancy: sonographic study. Radiology 164 (1987) 375-380
14. Phelan J.P. Myomas and pregnancy. Obstet Gynecol Clin North Am 22 (1995) 801-805
15. Muram D., Gillieson M., and Walters J.H. Myomas of the uterus in pregnancy: ultrasonographic follow-up. Am J Obstet Gynecol 138 (1980) 16-19
16. Stovall T.G., Solomon S.K., and Ling F.W. Endometrial sampling prior to hysterectomy. Obstet Gynecol 73 (1989) 405-409
17. Moller L.M., and Berget A. Prehysterectomy curettage in women with uterine fibromyomata is not worthwhile. Acta Obstet Gynecol Scand 72 (1993) 374-376
18. Fayez J.A., Mutie G., and Schneider P.J. The diagnostic value of hysterosalpingography and hysteroscopy in infertility investigation. Am J Obstet Gynecol 156 (1987) 558-560
19. Cohen L.S., and Valle R.F. Role of vaginal sonography and hysterosonography in the endoscopic treatment of uterine myomas. Fertil Steril 73 (2000) 197-204
20. Surrey E.S., Lietz A.K., and Schoolcraft W.B. Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome. Fertil Steril 75 (2001) 405-410
21. Reiter R.C., Wagner P.L., and Gambone J.C. Routine hysterectomy for large asymptomatic uterine leiomyomata: a reappraisal. Obstet Gynecol 79 (1992) 481-484
22. Campbell S., Royston P., Bhan V., Whitehead M.I., and Collins W.P. Novel screening strategies for early ovarian cancer by transabdominal ultrasonography. Br J Obstet Gynaecol 97 (1990) 304-311
23. Stovall T.G., Summit Jr. R.L., Washburn S.A., and Ling F.W. Gonadotropin-releasing hormone agonist use before hysterectomy. discussion 1748-51. Am J Obstet Gynecol 170 (1994) 1744-1748
24. Iverson Jr. R.E., Chelmow D., Strohbehn K., Waldman L., and Evantash E.G. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet Gynecol 88 (1996) 415-419
25. Leibsohn S., d'Ablaing G., Mishell Jr. D.R., and Schlaerth J.B. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. discussion 974-6. Am J Obstet Gynecol 162 (1990) 968-974
26. Parker W.H., Fu Y.S., and Berek J.S. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83 (1994) 414-418
27. Goodman A.L. Progesterone therapy in uterine fibromyoma. J Clin Endocrinol 6 (1946) 405-408
28. Mixson W.T., and Hammond D.O. Response of fibromyomas to a progestin. Am J Obstet Gynecol 82 (1961) 754-760
29. Friedman A.J., Daly M., Juneau-Norcross M., Gleason R., Rein M.S., and LeBoff M. Longterm medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years. Hum Reprod 9 (1994) 1618-1625
30. Coutinho E.M., and Goncalves M.T. Long-term treatment of leiomyomas with gestrinone. Fertil Steril 51 (1989) 939-946
31. DeCherney A.H., Maheux R., and Polan M.L. A medical treatment for myomata uteri. Fertil Steril 39 (1983) 429-430
32. Murphy A.A., Kettel L.M., Morales A.J., Roberts V.J., and Yen S.S. Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab 76 (1993) 513-517
33. Coddington C.C., Collins R.L., Shawker T.H., Anderson R., Loriaux D.L., and Winkel C.A. Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri. Fertil Steril 45 (1986) 624-629
34. West C.P., Lumsden M.A., Lawson S., Williamson J., and Baird D.T. Shrinkage of uterine fibroids during therapy with goserelin (Zoladex): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depot. Fertil Steril 48 (1987) 45-51
35. Perl V., Marquez J., Schally A.V., Comaru-Schally A.M., Leal G., Zacharias S., et al. Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone. Fertil Steril 48 (1987) 383-389
36. Andreyko J.L., Blumenfeld Z., Marshall L.A., Monroe S.E., Hricak H., and Jaffe R.B. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging. Am J Obstet Gynecol 158 (1988) 903-910
37. Schlaff W.D., Zerhouni E.A., Huth J.A., Chen J., Damewood M.D., and Rock J.A. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Obstet Gynecol 74 (1989) 856-862
38. Friedman A.J., Harrison-Atlas D., Barbieri R.L., Benacerraf B., Gleason R., and Schiff I. A randomized, placebo-controlled, double-blind study evaluating the efficacy of leuprolide acetate depot in the treatment of uterine leiomyomata. Fertil Steril 51 (1989) 251-256
39. Carlson K.J., Miller B.A., and Fowler Jr. F.J. The Maine Women's Health Study: I. Outcomes of hysterectomy. Obstet Gynecol 83 (1994) 556-565
40. Lock F.R. Multiple myomectomy. Am J Obstet Gynecol 104 (1969) 642-650
41. Rubin I.C. Progress in myomectomy. Am J Obstet Gynecol 44 (1942) 196-212
42. Ginsburg E.S., Benson C.B., Garfield J.M., Gleason R.E., and Friedman A.J. The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril 60 (1993) 956-962
43. Frederick J., Fletcher H., Simeon D., Mullings A., and Hardie M. Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br J Obstet Gynaecol 101 (1994) 435-437
44. Tulandi T., Murray C., and Guralnick M. Adhesion formation and reproductive outcome after myomectomy and second-look laparoscopy. Obstet Gynecol 82 (1993) 213-215
45. The Myomectomy Adhesion Multicenter Study Group. An expanded polytetrafluoroethylene barrier (Gor-Tex Surgical Membrane) reduces post-myomectomy adhesion formation. Fertil Steril 63 (1995) 491-493
46. Diamond M.P., and Seprafilm Adhesion Study Group. Reduction of adhesions after uterine myomectomy by Seprafilm membrane (HAL-F): a blinded, prospective, randomized, multicenter clinical study. Fertil Steril 66 (1996) 904-910
47. Grow D.R., Coddington C.C., Hsiu J.G., Mikich Y., and Hodgen G.D. Role of hypoestrogenism or sex steroid antagonism in adhesion formation after myometrial surgery in primates. Fertil Steril 66 (1996) 140-147
48. Wright J.A., and Sharpe-Timms K.L. Gonadotropin-releasing hormone agonist therapy reduces postoperative adhesion formation and reformation after adhesiolysis in rat models for adhesion formation and endometriosis. Fertil Steril 63 (1995) 1094-1100
49. Dubuisson J.B., Lecuru F., Foulot H., Mandelbrot L., Aubriot F.X., and Mouly M. Myomectomy by laparoscopy: a preliminary report of 43 cases. Fertil Steril 56 (1991) 827-830
50. Reich H. Laparoscopic myomectomy. Obstet Gynecol Clin North Am 22 (1995) 757-780
51. Mais V., Ajossa S., Guerriero S., Mascia M., Solla E., and Melis G.B. Laparoscopic versus abdominal myomectomy: a prospective, randomized trial to evaluate benefits in early outcome. Am J Obstet Gynecol 174 (1996) 654-658
52. Dubuisson J.B., Chavet X., Chapron C., Gregorakis S.S., and Morice P. Uterine rupture during pregnancy after laparoscopic myomectomy. Hum Reprod 10 (1995) 1475-1477
53. Harris W.J. Uterine dehiscence following laparoscopic myomectomy. Obstet Gynecol 80 (1992) 545-546
54. Goodwin S.C., McLucas B., Lee M., Chen G., Perrella R., Vedantham S., et al. Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol 10 (1999) 1159-1165
55. Siskin G.P., Stainken B.F., Dowling K., Meo P., Ahn J., and Dolen E.G. Outpaient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients. J Vasc Interv Radiol 11 (2000) 305-311
56. Ciraru-Vigneron N., and Ravina J.H. Letter to the Editor reply. Fertil Steril 75 (2001) 1247-1248
57. Friedman A.J., Rein M.S., Harrison-Atlas D., Garfield J.M., and Doubilet P.M. A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril 52 (1989) 728-733
58. Hutchins Jr. F.L. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog. J Reprod Med 37 (1992) 699-702
59. Vercellini P., Bocciolone L., Colombo A., Vendola N., Meschia M., and Bolis G. Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia and uterine leiomyomas. Acta Obstet Gynecol Scand 72 (1993) 369-373
60. Lumsden M.A., West C.P., Thomas E., Coutts J., Hillier H., Thomas N., et al. Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids. Br J Obstet Gynaecol 101 (1994) 438-442
61. Ylikorkala O., Tiitinen A., Hulkko S., Kivinen S., and Nummi S. Decrease in symptoms, blood loss and uterine size with nafarelin acetate before abdominal hysterectomy: a placebo-controlled, double-blind study. Hum Reprod 10 (1995) 1470-1474
62. Golan A., Bukovsky I., Pansky M., Schneider D., Weinraub Z., and Caspi E. Pre-operative gonadotrophin-releasing hormone agonist treatment in surgery for uterine leiomyomata. Hum Reprod 8 (1993) 450-452
63. Benagiano G., Kivinen S.T., Fadini R., Cronje H., Klintorp S., and van der Spuy Z.M. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study. Fertil Steril 66 (1996) 223-229
64. Candiani G.B., Fedele L., Parazzini F., and Villa L. Risk of recurrence after myomectomy. Br J Obstet Gynaecol 98 (1991) 385-389
65. Malone L.J. Myomectomy: recurrence after removal of solitary and multiple myomas. Obstet Gynecol 34 (1969) 200-203
66. Verkauf B.S. Myomectomy for fertility enhancement and preservation. Fertil Steril 58 (1992) 1-15
67. Hallez J.P. Single-stage total hysteroscopic myomectomies; indications, techniques, and results. Fertil Steril 63 (1995) 703-708
68. Goldenberg M., Sivan E., Sharabi Z., Bider D., Rabinovici J., and Seidman D.S. Outcomes of hysteroscopic resection of submucous myomas for infertility. Fertil Steril 64 (1995) 714-716
69. Seracchioli R., Rossi S., Govoni F., Rossi E., Venturoli S., Bulletti C., et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 15 (2000) 2663-2668
70. Davids A. Myomectomy: surgical technique and results in a series of 1,150 cases. Am J Obstet Gynecol 63 (1952) 592-604